Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
NMRA
Stock Latest News
Company Announcements
Neumora Therapeutics Faces Nasdaq Non-Compliance Notice
5d ago
8K
NMRA
Premium
Company Announcements
Neumora Therapeutics’ Earnings Call: Progress Amid Challenges
6d ago
NMRA
Premium
Ratings
Neumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating
9d ago
NMRA
Premium
Ratings
Strategic Developments and Long-Term Growth Prospects for Neumora Therapeutics Amid Financial Stability Enhancements
9d ago
NMRA
Premium
Company Announcements
Neumora Therapeutics Reports Q1 2025 Financial Results
9d ago
NMRA
Premium
The Fly
Neumora Therapeutics reports Q1 EPS (42c), consensus (38c)
9d ago
NMRA
Premium
Pre-Earnings
Neumora Therapeutics, Inc. (NMRA) Q1 Earnings Cheat Sheet
12d ago
NMRA
Premium
The Fly
Galapagos CEO Paul Stoffels to retire, Henry Gosebruch named CEO of SpinCo
1M ago
GLPG
NMRA
Premium
Ratings
Neumora Therapeutics, Inc.: Strategic Advancements and Optimism Drive Buy Rating
1M ago
NMRA
Premium
The Fly
Tesla reports deliveries miss, Nintendo says Switch 2 out in June: Morning Buzz
2M ago
BB
UL
Premium
Ratings
Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study
2M ago
NMRA
Premium
The Fly
Neumora Therapeutics downgraded to Underperform from Buy at BofA
2M ago
NMRA
Premium
The Fly
Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair
3M ago
NMRA
Premium
The Fly
Johnson & Johnson discontinues depression program for aticaprant
3M ago
JNJ
NMRA
Premium
Ratings
Douglas Tsao Recommends ‘Buy’ for Neumora Therapeutics Due to Navacaprant’s Market Potential and Differentiated Pharmacology
3M ago
NMRA
Premium
The Fly
Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim
3M ago
JNJ
NMRA
Premium
Ratings
Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks
3M ago
NMRA
Premium
The Fly
Neumora Therapeutics downgraded to Hold from Buy at Stifel
3M ago
JNJ
NMRA
Premium
Ratings
Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays
3M ago
NMRA
Premium
The Fly
Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright
3M ago
NMRA
Premium
Company Announcements
Neumora Therapeutics Reports 2024 Financial Results and Updates
3M ago
NMRA
Premium
Company Announcements
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
3M ago
NMRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
